NCC gave 9 new fellowships in 2022 with 6 renewals totaling $702,000.
“For the past few years, NCC has exceeded its goals, increasing not only the total number of grants given but also total funds awarded. In fact, NCC increased its grant monies from $570,000 in 2020 to $678,000 in 2021 to $702,000 in 2022 – an aggregate three-year increase of $132,000 or over 23%.”
– Jerome Ritz, M.D.
Professor of Medicine, Harvard Medical School and Dana Farber Cancer Institute,
Executive Director, Connell O’Reilly Cell Manipulation and Gene
Transfer Laboratory, Dana-Farber Cancer Institute
Donate To Advance Cancer Research Today
We rely on your generosity to fund more and more new scientists conducting research in our Program areas. National Cancer Center and everyone afflicted with cancer needs your continuing financial support. Thank you in advance for your consideration.
– Regina English, Executive Director
“I have proudly served as Chair of National Cancer Center’s Scientific Advisory Board for 34 years. NCC’s mission “ to fund basic scientific cancer research” is essential. It fills a critical gap by providing financial support to promising young scientists, post-doctoral researchers who are often overlooked by private, governmental and institutional funders. Year after year, NCC reviews and underwrites with grants exceptional studies, basing our award decisions on the highest national evaluation standards — those of the National Institutes of Health. The NCC fellowship award recipients demonstrate great progress in advancing our knowledge for the prevention, detection and treatment of cancer. The goal: finding a cure.”
Duke University Medical Center
We are dedicated to seek out and provide financial support to researchers undertaking thorough, innovative, and promising studies on topics related to conquering cancer. In addition to the four dedicated programs below, NCC sometimes awards special grants to research projects which bear particular promise. Such NCC fellowships have funded research in the following areas: brain tumors, melanoma, DNA repair, anti-cancer therapies, gene mutations and targeted therapeutics. For specific information on those grants visit the Our Programs page.